William J. Caragol, Chairman and CEO of PositiveID called in to SmallCapVoice.com to discuss the follow-on contract for the U.S. Department of Homeland Security SenseNet Program Phase II, the Firefly Dx prototype system successfully detected the Zika virus, the new model of your Caregiver non-contact thermometer with Bluetooth capability by early 2017 to connect wirelessly with hospital equipment and health records, and more.
PositiveID Corporation (OTCQB: PSID) is a life sciences tools and diagnostics company with an extensive patent portfolio. PositiveID develops biological detection and diagnostics systems, specializing in the development of microfluidic systems for the automated preparation of and performance of biological assays. PositiveID is also a leader in the mobile technology vehicle market, with a focus on the laboratory market and homeland security. For more information on PositiveID, please visit http://www.psidcorp.com, or connect with PositiveID on Twitter, Facebook or LinkedIn.
This interview may include forward looking statements. These forward-looking statements generally are identified by the words “believe,” “project,” “estimate,” “become,” “plan,” “will,” and similar expressions. These forward-looking statements involve known and unknown risks as well as uncertainties, including those discussed in the following cautionary statements and elsewhere in this release. Although the Company believes that its expectations are based on reasonable assumptions, the actual results that the Company may achieve may differ materially from any forward-looking statements, which reflect the opinions of the management of the Company only as of the date hereof.